US 11666547
Methods for treating cognitive deficits in a subject having schizophrenia, bipolar disorder, or psychiatric depression, and exhibiting cognitive deficits by administering an antagonist of the Na+-K+-2Cl-cation-chloride cotransporter isoform 1 (NKCC1)
granted A61KA61K31/196A61K31/4365
Quick answer
US patent 11666547 (Methods for treating cognitive deficits in a subject having schizophrenia, bipolar disorder, or psychiatric depression, and exhibiting cognitive deficits by administering an antagonist of the Na+-K+-2Cl-cation-chloride cotransporter isoform 1 (NKCC1)) held by Northwestern University expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Northwestern University
- Grant date
- Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61K, A61K31/196, A61K31/4365, A61K31/57, A61K45/06